Empowering MENA Pharma: JianPai Technology Wraps Up an Inspiring Journey at Pharmaconex Egypt 2026
Empowering MENA Pharma: JianPai Technology Wraps Up an Inspiring Journey at Pharmaconex Egypt 2026
Cairo, Egypt – September 2026 — Zhejiang JianPai Technology Co., Ltd. proudly announces the successful conclusion of its participation at Pharmaconex Egypt 2026 (in association with CPHI), held from September 1 to September 3 at the Cairo International Convention Centre (CICC).
As the premier pharmaceutical manufacturing exhibition in the Middle East and North Africa (MENA) region, Pharmaconex 2026 provided the ideal stage for JianPai to showcase its cutting-edge solid oral dosage (OSD) processing solutions and connect with industry leaders across Egypt, the Middle East, and Africa.
A Bustling Booth H22: 30 Years of OSD Innovation on Full Display
Throughout the three-day event, Booth H22 attracted an overwhelming number of visitors, including plant managers, technical directors, procurement specialists, and formulation scientists.
Prominently highlighted across the booth were JianPai’s core corporate milestones:
30+ Years of Manufacturing Experience in high-end pharmaceutical machinery
150+ Proprietary Patents in solid dosage processing
3,000+ Satisfied Clients Worldwide across more than 50 countries and regions
Strict Adherence to WHO-cGMP and CE Standards
Visitors engaged in intensive, face-to-face technical consultations with our senior engineering team, examining detailed 3D layouts, technical specifications, and production case studies for modern oral solid dosage facilities.
High-Efficiency OSD Solutions That Stole the Spotlight
At this year’s Pharmaconex, regional manufacturers showed immense interest in upgrading local production capacity and optimizing energy efficiency. JianPai’s specialized solid dosage portfolio received exceptional feedback:
High-Efficiency Tablet Coating Systems: Designed with precision air handling, automated recipe management, and high-efficiency spray technology to achieve uniform coating with minimal batch-to-batch variation and low energy consumption.
High Shear Mixers & Wet Granulation Lines: Engineered for homogeneous mixing, robust binder addition, and reproducible granule density, fully complying with cGMP containment and clean-in-place (CIP) requirements.
Advanced Fluid Bed Dryers / Granulators: Featuring optimized air distribution plates and pulse jet filter cleaning, offering fast drying cycles, precise temperature regulation, and explosion-proof safety designs.
“The MENA pharmaceutical market is experiencing rapid growth, with higher expectations for regulatory compliance and operational efficiency than ever before,” stated a JianPai technical representative at Booth H22. “Pharmaconex gave us the opportunity to demonstrate how JianPai’s tailor-made OSD equipment delivers Tier-1 quality, cGMP compliance, and exceptional total cost of ownership (TCO) for local drug manufacturers.”
Strengthening Ties in the MENA Region
In addition to meeting longstanding partners, the JianPai delegation established over a hundred new connections with leading pharmaceutical laboratories and generic drug manufacturers from Egypt, Saudi Arabia, the UAE, Jordan, and North Africa. Multiple prospective project agreements regarding solid dosage facility upgrades and turnkey granulation lines were initiated on-site.
Missed Us at Pharmaconex Egypt 2026? Let’s Connect Today!
Although the exhibition has concluded, our partnership with the global pharmaceutical industry continues. If you were unable to meet us in Cairo, our technical experts are available for virtual consultations, equipment sizing, and customized production line proposals.
Skip to content 
EN 
RU 
KO 
JA 
TR 
ZH 
TH 
PT 
FR 
ES